SlideShare a Scribd company logo
1 of 22
1
By Linda Yamamoto, RN, PHN, BSN, MBA/HCA,
and Molly Marten, BA, MPH
Nursing2007, December
Earn 2.0 ANCC/AACN contact hours
Online: http://www.nursing2007.com
© 2007 Lippincott Williams & Wilkins
2
1. Discuss the transmission of methicillin-
resistant Staphylococcus aureus (MRSA)
infections.
2. Identify ways to prevent MRSA infections.
3. Identify ways to treat MRSA infections.
3
 Six interventions:
1. Deploy rapid response teams.
2. Prevent ventilator-associated pneumonia (VAP).
3. Prevent adverse drug events.
4. Prevent central line infections.
5. Prevent surgical site infections (SSIs).
6. Deliver evidence-based care to treat acute
myocardial infarction (MI).
4
 Goal is to prevent 5 million incidents of medical harm
in a 2-year period (12/06 to 12/08)
 Six additional interventions:
 Reduce surgical complications.
 Prevent harm from high-alert medications
 Prevent pressure ulcers
 Reduce methicillin-resistant Staphylococcus aureus (MRSA)
infection
 Deliver reliable, evidence-based care for heart failure
 Get boards on board by defining and spreading the best-known
leveraged processes for boards of directors
5
 Easily transmitted and drug resistant, MRSA
can survive on hands, clothing, environmental
surfaces, and equipment.
 About 126,000 hospitalized patients develop
MRSA infections each year.
 Over 5,000 of those patients die.
6
 Improve hand hygiene.
 Make fastidious environmental cleaning and
disinfection a priority.
 Consider performing active surveillance cultures.
 Identify colonized patients and implement
contact precautions.
 Implement and perform all interventions from
the central line bundle and the ventilator bundle.
7
 Staphylococcus aureus is commonly carried on
healthy people’s skin, nares, and perineum.
 It may cause superficial skin infections
treatable with beta-lactam inhibitors (such as
methicillin).
 Over time, some strains have become resistant.
 First cases of MRSA in the United States
occurred in the 1960s.
 Today, 46 out of 1,000 patients have MRSA.
8
 Using antibiotics appropriately is key.
 Encourage cultures before antibiotics are started,
and, if necessary, narrow the spectrum of antibiotics
based on culture results.
 Review all culture reports to ensure that bacteria are
sensitive to the prescribed antibiotics.
 Teach the patient how to use antibiotics:
 Take as prescribed
 Finish the course of treatment
 Don’t take someone else’s prescribed medication
9
 Community-associated MRSA (CA-MRSA)
 Causes skin and soft-tissue infections, such as boils, blisters,
abscesses, folliculitis, and carbuncles
 Also, fever and local warmth, swelling, pain, and purulent
drainage
 Health care-associated MRSA
 More highly drug resistant
 Causes more invasive infections, such as surgical site infection,
endocarditis, osteomyelitis, bacteremia, pneumonia
“According to the Centers for Disease Control and Prevention definition, a
diagnosis of CA-MRSA requires that the patient have no medical history of
MRSA or colonization and no risk factors associated with
health care–associated MRSA.”
10
 CA-MRSA
 Person-to-person by sharing personal items (clothing
and towels)
 Close contact
 Health care-associated MRSA
 Contaminated environmental surfaces
 Staff members
11
 Patients weakened by
disease or injury
 Recent hospitalization
or surgery
 An invasive device
 Surgical wound or
pressure ulcer
 Prolonged
hospitalization
 Severe underlying
illness
 Immunocompromised
status
 Undergoing dialysis
 I.V. drug abuse
 Diabetes
 Burns
 Dermatitis
 Previous exposure to
broad-spectrum
antibiotics
 Proximity to patient
colonized or infected
with MRSA
12
 Incision and drainage, followed by routine
wound care
 Broad-spectrum antibiotic, changed as
indicated based on susceptibility testing
 Local antibiograms should be used to guide
antibiotic therapy
13
1. Perform hand hygiene.
2. Make sure patient rooms are cleaned well and
often.
3. Actively look for MRSA.
4. Implement contact precautions to prevent
transmission.
5. Bundle up best practices.
14
 After each glove change and when entering
and exiting any patient’s room
 Alcohol-based sanitizers are a suitable
substitute as long as hands aren’t visibly soiled
or grossly contaminated.
 Use appropriate technique
 Focus on fingernails, nail beds, between fingers, and
around thumbs
 Keep jewelry to a minimum; clean under your rings
and watch
15
 MRSA survives for hours or days in the
environment.
 Surfaces and equipment must be cleaned,
especially between patients.
 Make sure that every item that comes out of a
MRSA patient’s room is cleaned.
 If patient is on contact precautions,
housekeeping should clean the room daily.
16
 Active surveillance refers to taking cultures of a
group of people to see if they’re colonized with
MRSA.
 Each infection-control program should evaluate
the benefit of active surveillance cultures.
 Some facilities culture all patients on admission;
others culture certain groups, such as ICU patients
or those being admitted from long-term care
facilities.
 A person colonized with MRSA carries the
bacteria; although he has no signs or symptoms, he
can transmit it to others.
17
 Reservoirs for MRSA
 Anterior nares (most common)
 Skin of the axillae, perineum, hands, arms
 Gastrointestinal tract
 Ostomy sites
 Pressure ulcers and other wounds
 Sputum
 Drug susceptibility testing can differentiate
MRSA from S. aureus
Active surveillance cultures of the anterior nares will identify 80% of
colonized adults. Cultures of clinical specimens identify patients
infected but won’t detect up to 85% of colonized patients.
18
 Active surveillance is controversial and
challenging.
 If used, it must be combined with other control
efforts, such as contact precautions.
 Be aware of facility transmission rates–it helps
reinforce what works well to stop transmission.
19
 Anatomic location – make sure the area from
which the specimen was taken is correct.
 Gram stain report – look for the presence of
white blood cells (indicates infection).
 Antibiogram – identifies susceptible and
resistant antibiotics.
 Organisms – know the epidemiology of the
isolated organism.
 Source
 Potential for multiple-drug resistance
 Mode of transmission
20
 Always wear a gown and gloves when caring
for infected or colonized patients.
 Always perform hand hygiene between
patients and as you leave each room and after
removing gloves.
 Follow contact precautions for those infected or
colonized.
Remember that a patient on contact precautions requires the
same level of care and attention as any other patient.
21
 Private room for those infected or colonized (if
not possible, use visual cues, such as signs or a
line on the floor to remind everyone).
 Cohort patients with MRSA, if necessary.
 Gloves and gowns for caregivers and visitors
(keep a supply handy).
 Use dedicated patient-care equipment or
disposable equipment.
 Clean equipment upon removal from room.
 Discontinue precautions when appropriate (at
least three negative cultures on separate days).
22
 A colonized patient is more likely to develop a
MRSA infection because he already has the
bacteria as part of his normal flora.
 Central line bundle and ventilator bundle
implemented to reduce or eliminate device-
related infections.
 Review these bundles in detail at
http://www.ihi.org.

More Related Content

What's hot

Vancomycin-Resistant Enterococci
Vancomycin-Resistant EnterococciVancomycin-Resistant Enterococci
Vancomycin-Resistant EnterococciMary Mwinga
 
Vancomycin Resistant Enterococci
Vancomycin Resistant EnterococciVancomycin Resistant Enterococci
Vancomycin Resistant Enterococcidrakmane
 
Blood Stream Infections
Blood Stream InfectionsBlood Stream Infections
Blood Stream InfectionsSandro Zorzi
 
Device associated hospital acquired infection (da hai)
Device associated hospital acquired infection (da hai)Device associated hospital acquired infection (da hai)
Device associated hospital acquired infection (da hai)Central Govt, India
 
Catheter Associated UTI Bundle
Catheter Associated UTI BundleCatheter Associated UTI Bundle
Catheter Associated UTI BundleApollo Hospitals
 
3. central line associated blood stream infection
3. central line associated blood stream infection3. central line associated blood stream infection
3. central line associated blood stream infectionChartwellPA
 
The Superbug MRSA !!
The Superbug MRSA !!The Superbug MRSA !!
The Superbug MRSA !!Aruna M Das
 
Catheter Associated Urinary Tract Infections (CAUTI)
Catheter Associated Urinary Tract Infections (CAUTI)Catheter Associated Urinary Tract Infections (CAUTI)
Catheter Associated Urinary Tract Infections (CAUTI)Ujjwal Shah
 
Blood stream infections- clinical microbiology
Blood stream infections- clinical microbiologyBlood stream infections- clinical microbiology
Blood stream infections- clinical microbiologySijo A
 
Catheter associated blood stream infections
Catheter associated blood stream infectionsCatheter associated blood stream infections
Catheter associated blood stream infectionsvijay dihora
 
Specific Multi-drug Resistance MRSA-VRSA-ESBL-KPC
 Specific Multi-drug Resistance MRSA-VRSA-ESBL-KPC Specific Multi-drug Resistance MRSA-VRSA-ESBL-KPC
Specific Multi-drug Resistance MRSA-VRSA-ESBL-KPCAIIMS, New Delhi, India
 
Nosocomial infection & control
Nosocomial infection & controlNosocomial infection & control
Nosocomial infection & controlKalpesh Zunjarrao
 

What's hot (20)

Mrsa
MrsaMrsa
Mrsa
 
MRSA INFECTIONS basics, implications, and prevention
MRSA INFECTIONSbasics, implications, and preventionMRSA INFECTIONSbasics, implications, and prevention
MRSA INFECTIONS basics, implications, and prevention
 
Vancomycin-Resistant Enterococci
Vancomycin-Resistant EnterococciVancomycin-Resistant Enterococci
Vancomycin-Resistant Enterococci
 
CLABSI
CLABSICLABSI
CLABSI
 
Vancomycin Resistant Enterococci
Vancomycin Resistant EnterococciVancomycin Resistant Enterococci
Vancomycin Resistant Enterococci
 
Blood Stream Infections
Blood Stream InfectionsBlood Stream Infections
Blood Stream Infections
 
MRSA
MRSAMRSA
MRSA
 
MRSA Infection and Symptoms
MRSA Infection and SymptomsMRSA Infection and Symptoms
MRSA Infection and Symptoms
 
Device associated hospital acquired infection (da hai)
Device associated hospital acquired infection (da hai)Device associated hospital acquired infection (da hai)
Device associated hospital acquired infection (da hai)
 
Catheter Associated UTI Bundle
Catheter Associated UTI BundleCatheter Associated UTI Bundle
Catheter Associated UTI Bundle
 
3. central line associated blood stream infection
3. central line associated blood stream infection3. central line associated blood stream infection
3. central line associated blood stream infection
 
Screening for MRSA
Screening for MRSAScreening for MRSA
Screening for MRSA
 
The Superbug MRSA !!
The Superbug MRSA !!The Superbug MRSA !!
The Superbug MRSA !!
 
Catheter Associated Urinary Tract Infection (CAUTI)
Catheter Associated Urinary Tract Infection (CAUTI)Catheter Associated Urinary Tract Infection (CAUTI)
Catheter Associated Urinary Tract Infection (CAUTI)
 
Catheter Associated Urinary Tract Infections (CAUTI)
Catheter Associated Urinary Tract Infections (CAUTI)Catheter Associated Urinary Tract Infections (CAUTI)
Catheter Associated Urinary Tract Infections (CAUTI)
 
Blood stream infections- clinical microbiology
Blood stream infections- clinical microbiologyBlood stream infections- clinical microbiology
Blood stream infections- clinical microbiology
 
Catheter associated blood stream infections
Catheter associated blood stream infectionsCatheter associated blood stream infections
Catheter associated blood stream infections
 
Cauti ppt
Cauti pptCauti ppt
Cauti ppt
 
Specific Multi-drug Resistance MRSA-VRSA-ESBL-KPC
 Specific Multi-drug Resistance MRSA-VRSA-ESBL-KPC Specific Multi-drug Resistance MRSA-VRSA-ESBL-KPC
Specific Multi-drug Resistance MRSA-VRSA-ESBL-KPC
 
Nosocomial infection & control
Nosocomial infection & controlNosocomial infection & control
Nosocomial infection & control
 

Viewers also liked

Superbug selection and associated clinical and non clinical
Superbug selection and associated clinical and non clinicalSuperbug selection and associated clinical and non clinical
Superbug selection and associated clinical and non clinicalKarthik Kumaragurubaran
 
Sales Management in the Pharma. Industry - An overview
Sales Management in the Pharma. Industry - An overviewSales Management in the Pharma. Industry - An overview
Sales Management in the Pharma. Industry - An overviewSarthak Athavle
 
Antibiotics In Acute Respiratory Failure
Antibiotics In Acute Respiratory FailureAntibiotics In Acute Respiratory Failure
Antibiotics In Acute Respiratory Failureshabeel pn
 
Universal Precautions
Universal PrecautionsUniversal Precautions
Universal PrecautionsDuane Embry
 
Multidrug Resistant Oraganisms (MDRO) infection control
Multidrug Resistant Oraganisms (MDRO) infection controlMultidrug Resistant Oraganisms (MDRO) infection control
Multidrug Resistant Oraganisms (MDRO) infection controlMostafa Mahmoud
 
Pharmaceutical Sales Skills
Pharmaceutical Sales SkillsPharmaceutical Sales Skills
Pharmaceutical Sales Skillssghosh71190
 
Pharmacology of Antibiotics
Pharmacology of  AntibioticsPharmacology of  Antibiotics
Pharmacology of AntibioticsAmr Rafat
 
Nimalox re-branding marketing plan
Nimalox re-branding marketing planNimalox re-branding marketing plan
Nimalox re-branding marketing planMahmoUd Nasa
 
Newer antibiotics and uses
Newer antibiotics and usesNewer antibiotics and uses
Newer antibiotics and usesSujit Shrestha
 
Dispercam Marketing Plan @AxTantawy
Dispercam Marketing Plan @AxTantawyDispercam Marketing Plan @AxTantawy
Dispercam Marketing Plan @AxTantawyAbdelrhman Tantawy
 
Marketing Plan Final
Marketing Plan FinalMarketing Plan Final
Marketing Plan FinalTeeka
 
Marketing Plan of Esomeprazole
Marketing Plan of EsomeprazoleMarketing Plan of Esomeprazole
Marketing Plan of EsomeprazoleAnimesh Gupta
 
Pharma Plan Presentation Powerpoint
Pharma Plan Presentation PowerpointPharma Plan Presentation Powerpoint
Pharma Plan Presentation Powerpointwaschmaschine
 
Pharmaceutical marketing course
Pharmaceutical marketing coursePharmaceutical marketing course
Pharmaceutical marketing courseMadhukar Tanna
 
Antibiotic principles
Antibiotic principlesAntibiotic principles
Antibiotic principlesK.J Mokori
 
Pharmaceutical Marketing Presentation
Pharmaceutical Marketing PresentationPharmaceutical Marketing Presentation
Pharmaceutical Marketing Presentationnilbert
 

Viewers also liked (20)

Superbug selection and associated clinical and non clinical
Superbug selection and associated clinical and non clinicalSuperbug selection and associated clinical and non clinical
Superbug selection and associated clinical and non clinical
 
Sales Management in the Pharma. Industry - An overview
Sales Management in the Pharma. Industry - An overviewSales Management in the Pharma. Industry - An overview
Sales Management in the Pharma. Industry - An overview
 
Panadol ppt
Panadol pptPanadol ppt
Panadol ppt
 
Antibiotic update in icu
Antibiotic update in icuAntibiotic update in icu
Antibiotic update in icu
 
Antibiotics In Acute Respiratory Failure
Antibiotics In Acute Respiratory FailureAntibiotics In Acute Respiratory Failure
Antibiotics In Acute Respiratory Failure
 
Universal Precautions
Universal PrecautionsUniversal Precautions
Universal Precautions
 
Multidrug Resistant Oraganisms (MDRO) infection control
Multidrug Resistant Oraganisms (MDRO) infection controlMultidrug Resistant Oraganisms (MDRO) infection control
Multidrug Resistant Oraganisms (MDRO) infection control
 
Pharmaceutical Sales Skills
Pharmaceutical Sales SkillsPharmaceutical Sales Skills
Pharmaceutical Sales Skills
 
antibiotics
antibioticsantibiotics
antibiotics
 
Pharmacology of Antibiotics
Pharmacology of  AntibioticsPharmacology of  Antibiotics
Pharmacology of Antibiotics
 
Nimalox re-branding marketing plan
Nimalox re-branding marketing planNimalox re-branding marketing plan
Nimalox re-branding marketing plan
 
Newer antibiotics and uses
Newer antibiotics and usesNewer antibiotics and uses
Newer antibiotics and uses
 
Dispercam Marketing Plan @AxTantawy
Dispercam Marketing Plan @AxTantawyDispercam Marketing Plan @AxTantawy
Dispercam Marketing Plan @AxTantawy
 
Marketing Plan Final
Marketing Plan FinalMarketing Plan Final
Marketing Plan Final
 
Esomeprazole plan
Esomeprazole planEsomeprazole plan
Esomeprazole plan
 
Marketing Plan of Esomeprazole
Marketing Plan of EsomeprazoleMarketing Plan of Esomeprazole
Marketing Plan of Esomeprazole
 
Pharma Plan Presentation Powerpoint
Pharma Plan Presentation PowerpointPharma Plan Presentation Powerpoint
Pharma Plan Presentation Powerpoint
 
Pharmaceutical marketing course
Pharmaceutical marketing coursePharmaceutical marketing course
Pharmaceutical marketing course
 
Antibiotic principles
Antibiotic principlesAntibiotic principles
Antibiotic principles
 
Pharmaceutical Marketing Presentation
Pharmaceutical Marketing PresentationPharmaceutical Marketing Presentation
Pharmaceutical Marketing Presentation
 

Similar to Preventing the Spread of MRSA Infections

Mdro infection controlnursing final version 11.17.09 1
Mdro infection controlnursing final version 11.17.09 1Mdro infection controlnursing final version 11.17.09 1
Mdro infection controlnursing final version 11.17.09 1capstonerx
 
Prevention strategy for mdro in hospital
Prevention strategy for mdro in hospitalPrevention strategy for mdro in hospital
Prevention strategy for mdro in hospitalMoustapha Ramadan
 
Inf control for hcw 2012
Inf control for hcw 2012Inf control for hcw 2012
Inf control for hcw 2012Lee Oi Wah
 
Hand hygience usp infection control dr.rs 14 06-2017
Hand hygience usp infection control dr.rs 14 06-2017Hand hygience usp infection control dr.rs 14 06-2017
Hand hygience usp infection control dr.rs 14 06-2017SOMESHWARAN R
 
Role of nurses in infection control dr.rs 07 04-2016
Role of nurses in infection control dr.rs 07 04-2016Role of nurses in infection control dr.rs 07 04-2016
Role of nurses in infection control dr.rs 07 04-2016SOMESHWARAN R
 
Hospital Infection Control
Hospital Infection ControlHospital Infection Control
Hospital Infection ControlNc Das
 
Hospital Aquired Infections and infection control in a healthcare setup
Hospital Aquired Infections and infection control in a healthcare setupHospital Aquired Infections and infection control in a healthcare setup
Hospital Aquired Infections and infection control in a healthcare setupSumi Nandwani
 
Hospital Acquired Infections
Hospital Acquired InfectionsHospital Acquired Infections
Hospital Acquired InfectionsLisa Olive
 
Hospital Infection Control Guidelines-LECTURE (4).pptx
Hospital Infection Control Guidelines-LECTURE (4).pptxHospital Infection Control Guidelines-LECTURE (4).pptx
Hospital Infection Control Guidelines-LECTURE (4).pptxemmanueladdo39
 
PREVENTION OF CORONA VIRUS INFECTION AMONG HEALTH WORKERS & PATIENTS
PREVENTION OF CORONA VIRUS INFECTION AMONG HEALTH WORKERS & PATIENTSPREVENTION OF CORONA VIRUS INFECTION AMONG HEALTH WORKERS & PATIENTS
PREVENTION OF CORONA VIRUS INFECTION AMONG HEALTH WORKERS & PATIENTSSANJAY SIR
 
Please answer original forum with a minimum of 300 wordsPlease
Please answer original forum with a minimum of 300 wordsPleasePlease answer original forum with a minimum of 300 wordsPlease
Please answer original forum with a minimum of 300 wordsPleaseisbelsejx0m
 
Challenges in healthcare and infection control
Challenges in healthcare and infection controlChallenges in healthcare and infection control
Challenges in healthcare and infection controlLee Oi Wah
 
Epcm l15 control of nosocomial (Hospital-Acquired) infection
Epcm l15 control of nosocomial (Hospital-Acquired) infectionEpcm l15 control of nosocomial (Hospital-Acquired) infection
Epcm l15 control of nosocomial (Hospital-Acquired) infectionDr Ghaiath Hussein
 

Similar to Preventing the Spread of MRSA Infections (20)

Mdro infection controlnursing final version 11.17.09 1
Mdro infection controlnursing final version 11.17.09 1Mdro infection controlnursing final version 11.17.09 1
Mdro infection controlnursing final version 11.17.09 1
 
Infection control in icu
Infection control in icuInfection control in icu
Infection control in icu
 
Prevention strategy for mdro in hospital
Prevention strategy for mdro in hospitalPrevention strategy for mdro in hospital
Prevention strategy for mdro in hospital
 
Infection control
Infection controlInfection control
Infection control
 
Inf control for hcw 2012
Inf control for hcw 2012Inf control for hcw 2012
Inf control for hcw 2012
 
Hand hygience usp infection control dr.rs 14 06-2017
Hand hygience usp infection control dr.rs 14 06-2017Hand hygience usp infection control dr.rs 14 06-2017
Hand hygience usp infection control dr.rs 14 06-2017
 
Role of nurses in infection control dr.rs 07 04-2016
Role of nurses in infection control dr.rs 07 04-2016Role of nurses in infection control dr.rs 07 04-2016
Role of nurses in infection control dr.rs 07 04-2016
 
Hospital Infection Control
Hospital Infection ControlHospital Infection Control
Hospital Infection Control
 
module 19 PPT.pdf
module 19 PPT.pdfmodule 19 PPT.pdf
module 19 PPT.pdf
 
Pt. safety & ic
Pt. safety & icPt. safety & ic
Pt. safety & ic
 
Hospital Aquired Infections and infection control in a healthcare setup
Hospital Aquired Infections and infection control in a healthcare setupHospital Aquired Infections and infection control in a healthcare setup
Hospital Aquired Infections and infection control in a healthcare setup
 
Infection control sandra
Infection control sandraInfection control sandra
Infection control sandra
 
Hospital Acquired Infections
Hospital Acquired InfectionsHospital Acquired Infections
Hospital Acquired Infections
 
Hospital Infection Control Guidelines-LECTURE (4).pptx
Hospital Infection Control Guidelines-LECTURE (4).pptxHospital Infection Control Guidelines-LECTURE (4).pptx
Hospital Infection Control Guidelines-LECTURE (4).pptx
 
Oncology Unit
Oncology UnitOncology Unit
Oncology Unit
 
PREVENTION OF CORONA VIRUS INFECTION AMONG HEALTH WORKERS & PATIENTS
PREVENTION OF CORONA VIRUS INFECTION AMONG HEALTH WORKERS & PATIENTSPREVENTION OF CORONA VIRUS INFECTION AMONG HEALTH WORKERS & PATIENTS
PREVENTION OF CORONA VIRUS INFECTION AMONG HEALTH WORKERS & PATIENTS
 
infection control in dentistry
infection control in dentistryinfection control in dentistry
infection control in dentistry
 
Please answer original forum with a minimum of 300 wordsPlease
Please answer original forum with a minimum of 300 wordsPleasePlease answer original forum with a minimum of 300 wordsPlease
Please answer original forum with a minimum of 300 wordsPlease
 
Challenges in healthcare and infection control
Challenges in healthcare and infection controlChallenges in healthcare and infection control
Challenges in healthcare and infection control
 
Epcm l15 control of nosocomial (Hospital-Acquired) infection
Epcm l15 control of nosocomial (Hospital-Acquired) infectionEpcm l15 control of nosocomial (Hospital-Acquired) infection
Epcm l15 control of nosocomial (Hospital-Acquired) infection
 

More from SCramer123

Brown recluse spider myth of the
Brown recluse spider myth of theBrown recluse spider myth of the
Brown recluse spider myth of theSCramer123
 
Neuro assessment hdsp final 10.09
Neuro assessment hdsp final 10.09Neuro assessment hdsp final 10.09
Neuro assessment hdsp final 10.09SCramer123
 
Neuro assessment hdsp final 10.09
Neuro assessment hdsp final 10.09Neuro assessment hdsp final 10.09
Neuro assessment hdsp final 10.09SCramer123
 
Chest pain 2009 ppt
Chest pain 2009 pptChest pain 2009 ppt
Chest pain 2009 pptSCramer123
 
Rattlesnake bite
Rattlesnake biteRattlesnake bite
Rattlesnake biteSCramer123
 
Spinal immobilization.ppt 2
Spinal immobilization.ppt 2Spinal immobilization.ppt 2
Spinal immobilization.ppt 2SCramer123
 

More from SCramer123 (8)

Scabies ppt
Scabies pptScabies ppt
Scabies ppt
 
Bored at work
Bored at workBored at work
Bored at work
 
Brown recluse spider myth of the
Brown recluse spider myth of theBrown recluse spider myth of the
Brown recluse spider myth of the
 
Neuro assessment hdsp final 10.09
Neuro assessment hdsp final 10.09Neuro assessment hdsp final 10.09
Neuro assessment hdsp final 10.09
 
Neuro assessment hdsp final 10.09
Neuro assessment hdsp final 10.09Neuro assessment hdsp final 10.09
Neuro assessment hdsp final 10.09
 
Chest pain 2009 ppt
Chest pain 2009 pptChest pain 2009 ppt
Chest pain 2009 ppt
 
Rattlesnake bite
Rattlesnake biteRattlesnake bite
Rattlesnake bite
 
Spinal immobilization.ppt 2
Spinal immobilization.ppt 2Spinal immobilization.ppt 2
Spinal immobilization.ppt 2
 

Preventing the Spread of MRSA Infections

  • 1. 1 By Linda Yamamoto, RN, PHN, BSN, MBA/HCA, and Molly Marten, BA, MPH Nursing2007, December Earn 2.0 ANCC/AACN contact hours Online: http://www.nursing2007.com © 2007 Lippincott Williams & Wilkins
  • 2. 2 1. Discuss the transmission of methicillin- resistant Staphylococcus aureus (MRSA) infections. 2. Identify ways to prevent MRSA infections. 3. Identify ways to treat MRSA infections.
  • 3. 3  Six interventions: 1. Deploy rapid response teams. 2. Prevent ventilator-associated pneumonia (VAP). 3. Prevent adverse drug events. 4. Prevent central line infections. 5. Prevent surgical site infections (SSIs). 6. Deliver evidence-based care to treat acute myocardial infarction (MI).
  • 4. 4  Goal is to prevent 5 million incidents of medical harm in a 2-year period (12/06 to 12/08)  Six additional interventions:  Reduce surgical complications.  Prevent harm from high-alert medications  Prevent pressure ulcers  Reduce methicillin-resistant Staphylococcus aureus (MRSA) infection  Deliver reliable, evidence-based care for heart failure  Get boards on board by defining and spreading the best-known leveraged processes for boards of directors
  • 5. 5  Easily transmitted and drug resistant, MRSA can survive on hands, clothing, environmental surfaces, and equipment.  About 126,000 hospitalized patients develop MRSA infections each year.  Over 5,000 of those patients die.
  • 6. 6  Improve hand hygiene.  Make fastidious environmental cleaning and disinfection a priority.  Consider performing active surveillance cultures.  Identify colonized patients and implement contact precautions.  Implement and perform all interventions from the central line bundle and the ventilator bundle.
  • 7. 7  Staphylococcus aureus is commonly carried on healthy people’s skin, nares, and perineum.  It may cause superficial skin infections treatable with beta-lactam inhibitors (such as methicillin).  Over time, some strains have become resistant.  First cases of MRSA in the United States occurred in the 1960s.  Today, 46 out of 1,000 patients have MRSA.
  • 8. 8  Using antibiotics appropriately is key.  Encourage cultures before antibiotics are started, and, if necessary, narrow the spectrum of antibiotics based on culture results.  Review all culture reports to ensure that bacteria are sensitive to the prescribed antibiotics.  Teach the patient how to use antibiotics:  Take as prescribed  Finish the course of treatment  Don’t take someone else’s prescribed medication
  • 9. 9  Community-associated MRSA (CA-MRSA)  Causes skin and soft-tissue infections, such as boils, blisters, abscesses, folliculitis, and carbuncles  Also, fever and local warmth, swelling, pain, and purulent drainage  Health care-associated MRSA  More highly drug resistant  Causes more invasive infections, such as surgical site infection, endocarditis, osteomyelitis, bacteremia, pneumonia “According to the Centers for Disease Control and Prevention definition, a diagnosis of CA-MRSA requires that the patient have no medical history of MRSA or colonization and no risk factors associated with health care–associated MRSA.”
  • 10. 10  CA-MRSA  Person-to-person by sharing personal items (clothing and towels)  Close contact  Health care-associated MRSA  Contaminated environmental surfaces  Staff members
  • 11. 11  Patients weakened by disease or injury  Recent hospitalization or surgery  An invasive device  Surgical wound or pressure ulcer  Prolonged hospitalization  Severe underlying illness  Immunocompromised status  Undergoing dialysis  I.V. drug abuse  Diabetes  Burns  Dermatitis  Previous exposure to broad-spectrum antibiotics  Proximity to patient colonized or infected with MRSA
  • 12. 12  Incision and drainage, followed by routine wound care  Broad-spectrum antibiotic, changed as indicated based on susceptibility testing  Local antibiograms should be used to guide antibiotic therapy
  • 13. 13 1. Perform hand hygiene. 2. Make sure patient rooms are cleaned well and often. 3. Actively look for MRSA. 4. Implement contact precautions to prevent transmission. 5. Bundle up best practices.
  • 14. 14  After each glove change and when entering and exiting any patient’s room  Alcohol-based sanitizers are a suitable substitute as long as hands aren’t visibly soiled or grossly contaminated.  Use appropriate technique  Focus on fingernails, nail beds, between fingers, and around thumbs  Keep jewelry to a minimum; clean under your rings and watch
  • 15. 15  MRSA survives for hours or days in the environment.  Surfaces and equipment must be cleaned, especially between patients.  Make sure that every item that comes out of a MRSA patient’s room is cleaned.  If patient is on contact precautions, housekeeping should clean the room daily.
  • 16. 16  Active surveillance refers to taking cultures of a group of people to see if they’re colonized with MRSA.  Each infection-control program should evaluate the benefit of active surveillance cultures.  Some facilities culture all patients on admission; others culture certain groups, such as ICU patients or those being admitted from long-term care facilities.  A person colonized with MRSA carries the bacteria; although he has no signs or symptoms, he can transmit it to others.
  • 17. 17  Reservoirs for MRSA  Anterior nares (most common)  Skin of the axillae, perineum, hands, arms  Gastrointestinal tract  Ostomy sites  Pressure ulcers and other wounds  Sputum  Drug susceptibility testing can differentiate MRSA from S. aureus Active surveillance cultures of the anterior nares will identify 80% of colonized adults. Cultures of clinical specimens identify patients infected but won’t detect up to 85% of colonized patients.
  • 18. 18  Active surveillance is controversial and challenging.  If used, it must be combined with other control efforts, such as contact precautions.  Be aware of facility transmission rates–it helps reinforce what works well to stop transmission.
  • 19. 19  Anatomic location – make sure the area from which the specimen was taken is correct.  Gram stain report – look for the presence of white blood cells (indicates infection).  Antibiogram – identifies susceptible and resistant antibiotics.  Organisms – know the epidemiology of the isolated organism.  Source  Potential for multiple-drug resistance  Mode of transmission
  • 20. 20  Always wear a gown and gloves when caring for infected or colonized patients.  Always perform hand hygiene between patients and as you leave each room and after removing gloves.  Follow contact precautions for those infected or colonized. Remember that a patient on contact precautions requires the same level of care and attention as any other patient.
  • 21. 21  Private room for those infected or colonized (if not possible, use visual cues, such as signs or a line on the floor to remind everyone).  Cohort patients with MRSA, if necessary.  Gloves and gowns for caregivers and visitors (keep a supply handy).  Use dedicated patient-care equipment or disposable equipment.  Clean equipment upon removal from room.  Discontinue precautions when appropriate (at least three negative cultures on separate days).
  • 22. 22  A colonized patient is more likely to develop a MRSA infection because he already has the bacteria as part of his normal flora.  Central line bundle and ventilator bundle implemented to reduce or eliminate device- related infections.  Review these bundles in detail at http://www.ihi.org.